Abstract Details

Title Influence of on-going Treatment with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker on the Outcome of Patients treated with Intravenous rt-PA for Ischemic Stroke

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) S54 - (-)

Poster/Presentation
Number 005

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Sixtine GILLIOT PRESENTER	No disclosure on file
Igor Sibon (Hopital Pellegrin)	No disclosure on file
	No disclosure on file
Thierry B. Moulin, MD, PhD (CHU Besancon)	No disclosure on file
Yannick Bejot	No disclosure on file
	No disclosure on file
Maurice Giroud	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Didier Leys, MD, FAAN	The institution of Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.